Loading organizations...
Loading organizations...
Plant Response is a technology company.
Plant Response develops biological agricultural technologies designed to enhance plant health and resilience. The company crafts advanced solutions for mitigating botanical stress and optimizing crop nutrition. Leveraging scientific understanding of plant defense mechanisms, Plant Response formulates products enabling crops to withstand challenges and improve growth through sustainable practices.
Co-founded in 2008 by Antonio Molina Fernández, a distinguished scientist, Plant Response emerged from his extensive research into plant immunity mechanisms. His profound insights into how plants naturally respond to stress and disease provided the foundational scientific premise. This deep understanding of intrinsic plant biology catalyzed translating discoveries into practical agricultural solutions.
Plant Response's biological solutions serve growers and agricultural enterprises seeking effective, environmentally sound methods to improve crop yields and quality. The company envisions a future where agriculture increasingly integrates biological intelligence to safeguard plant health. Its long-term goal is to innovate in bio-based agricultural inputs, fostering a sustainable global food system.
Plant Response has raised $7.0M across 1 funding round.
Plant Response has raised $7.0M in total across 1 funding round.
Plant Response Biotech S.L. is a Spanish plant biotechnology company that develops sustainable agricultural solutions focused on enhancing plant innate immunity, physiology, and nutrient use efficiency to address crop challenges like stress and growth limitations.[1] Founded as a spin-off from Universidad Politécnica de Madrid in 2008, it bridges pioneering research with market needs through innovative products under worldwide exclusive licenses, positioning it as a leader in the expanding agricultural biotech sector.[1]
Separately, Plant Response Inc., a U.S.-based firm, acted as an industry consolidator of biologics, recovered waste fertilizers, and crop inputs, acquiring entities like Koch Biological Solutions (2019), Pathway BioLogic (2020), and WISErg (2021) to build a portfolio of 16 products improving nutrient efficiency, disease defense, stress tolerance, and yields.[2] Acquired by The Mosaic Company and rebranded as Mosaic Biosciences™, it now integrates biological technologies with Mosaic's crop nutrition expertise to activate plant-soil-microbiome potential, serving growers via enhanced nutrient access and stress management.[2][3]
Plant Response Biotech emerged in March 2008 as a spin-off from Universidad Politécnica de Madrid (UPM), leveraging the founders' expertise in plant science and agricultural techniques to commercialize research into botanical stress solutions and plant growth enhancement.[1] Early focus centered on innovative products from licensed UPM technologies, evolving into a global player with world-class potential in agricultural biotech by pursuing scientific excellence.[1]
Plant Response Inc. formed through a consolidation strategy, uniting diverse businesses and investors with varying exit horizons, culminating in its 2022 acquisition by The Mosaic Company—a major fertilizer and chemicals player—to accelerate commercialization and pipeline development.[2] Post-acquisition, it rebranded as Mosaic Biosciences™, expanding Mosaic's offerings into science-based biologicals for crop nutrition and resilience.[3]
(Note: Plant Health Care's PREtec technology, while related to plant response elicitors inspired by harpin proteins, represents a distinct platform from Plant Response entities, with products like Saori® (2021) and Obrona® (2023).[4])
Plant Response Biotech rides the wave of sustainable agriculture biotech, addressing global crop challenges amid climate pressures and food security demands through research-driven innovations in plant immunity and efficiency.[1] Its spin-off model exemplifies how academic tech transfer fuels market-ready solutions in a sector growing due to regulatory pushes for eco-friendly alternatives to chemicals.
Plant Response Inc.'s consolidation and Mosaic integration taps into the booming biologics market (expanding >16% annually per related trends), where fragmented players merge to scale amid demand for microbiome-enhanced nutrition and resilience.[2][3][4] Market forces like fertilizer efficiency needs and abiotic stress from climate change favor its timing, influencing the ecosystem by mainstreaming biologicals within major agribusinesses like Mosaic, accelerating adoption and consolidation.[2][3]
Plant Response Biotech is poised for expanded global licensing and product launches, capitalizing on biotech momentum to lead in stress-resilient crops amid rising sustainability demands.[1] Mosaic Biosciences™ will drive commercial growth through Mosaic's distribution, innovating pipeline biologicals to optimize fertilizer use and soil health in a microbiome-focused ag era.[2][3]
Shaping trends include climate-adaptive farming and biologics consolidation; their influence may evolve by setting standards for integrated nutrition tech, with Plant Response Biotech pioneering European innovation and Mosaic Biosciences scaling U.S.-led solutions worldwide—ultimating the promise of biotech to boost yields sustainably.
Plant Response has raised $7.0M in total across 1 funding round.
Plant Response's investors include Monsanto Growth Ventures, DCVC (Data Collective), Faber, Caixa Capital Risc, Middleland Capital, Novozymes.
Plant Response has raised $7.0M across 1 funding round. Most recently, it raised $7.0M Series A in November 2015.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 1, 2015 | $7.0M Series A | Monsanto Growth Ventures | DCVC (Data Collective), Faber, Caixa Capital Risc, Middleland Capital, Novozymes |